TABLE 4.
Derivative and dose | Model | Experimental outcome | Reference |
Naringin | |||
15 and 30 mg/ kg bw | STZ-induced diabetic rats | Decreased activities of glucose-6-phosphatase and fructose-1,6-bisphosphatase in liver and kidney | (79) |
Increased activities of hexokinase | |||
0.2 g/kg diet | C57BL/KsJ-db/db mice | Hepatic glucokinase activity and glycogen concentration were both significantly elevated | (80) |
Lowered the activity of hepatic glucose-6-phosphatase and phosphoenolpyruvate carboxykinase | |||
15 and 30 mg/ kg bw | STZ-induced diabetic rats | Increased activity of hexokinase and decreased the activities of glucose-6-phosphatase and fructose-1,6-bisphosphatase in liver and kidney | (79) |
Normalized the concentrations of plasma TBARS, lipid hydroperoxides and vitamin E and reduced glutathione in diabetic rats | |||
Naringenin | |||
50 mg · kg bw · d | Experimental STZ-nicotinamide–induced diabetes | Significantly lowered mean concentrations of fasting blood glucose and glycosylated hemoglobin and significantly elevated serum insulin concentrations | (81) |
Lowered mean activities of ALT, AST, ALP, and LDH in serum | |||
50 mg · kg bw−1 · d−1 | Experimental STZ-nicotinamide–induced diabetes | Naringenin ameliorated hyperglycemia-mediated inflammation | (82) |
0.5%, 1%, and 2% of the diet | Diabetic mice | Naringenin treatments at 1% and 2% of diet lowered plasma concentrations of glucose and blood urea nitrogen | (83) |
Increased insulin concentrations and creatinine clearance | |||
Decreased production and expression of IL-1β, IL-6, and MCP-1 | |||
75 μmol/L | Skeletal muscle cells (L6 myotubes) | No significant effect on insulin-stimulated Akt phosphorylation and significantly increased AMPK phosphorylation/activation | (84) |
Increased glucose uptake by skeletal muscle cells in an AMPK-dependent manner. |
Akt, protein kinase B; ALP, alkaline phosphatase; ALT, alanine transaminase; AMPK, AMP kinase; AST, aspertate transaminase; bw, body weight; LDH, lactate dehydrogenase; STZ, streptozotocin.